Role ofjoints hypermobility in diagnostics of syndromic forms of conjunctive tissue dysplasia and rheumatic disorders


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Hypermobility of the joints is a very common condition (from 6 to 57% in different populations), in which the amplitude of active and/ or passive movements in the joints exceeds the conventional average statistical rate. Hypermobility of the joints is one of the frequent manifestations of both undifferentiated and differentiated (syndromic) forms of connective tissue dysplasia. It can be a harbinger of systemic connective tissue diseases in combination with musculoskeletal pain syndrome.

Texto integral

Acesso é fechado

Sobre autores

Inna Viktorova

FSBEI of Higher Education Omsk state medical university of the Ministry of Health of Russia

Email: ovpomsk@mail.ru
MD, professor, head of the Department of internal medicine and polyclinic therapy

Daria Ivanova

FSBEI of Higher Education Omsk state medical university of the Ministry of Health of Russia

Email: ovpomsk@mail.ru
MD, associate professor of the Department of internal medicine and polyclinic therapy

Nadezhda Konshu

FSBEI of Higher Education Omsk state medical university of the Ministry of Health of Russia

Email: nadias@mail.ru
PhD, assistant of the Department of internal medicine and polyclinic therapy

Maria Rozhina

Kabanov AN city clinical hospital № 1

General Practitioner of the Department of general practitioners No. 1

Bibliografia

  1. Национальные рекомендации российского научного медицинского общества терапевтов по диагностике, лечению и реабилитации пациентов с дисплазиями соединительной ткани. Медицинский вестник Северного Кавказа. 2016. Т. 11. № 1. С. 2-76.
  2. Яковлев В.М., Нечаева Г.И., Мартынов А.И., Викторова И.А. Дисплазия соединительной ткани в практике врачей первичного звена здравоохранения: Руководство для врачей. М.: КСТ Интерфорум, 2016. 520 с.
  3. Celletti C. Evaluation of lower limb disability in joint hypermobility syndrome. Rheumatol. Int. 2012; 32 (8): 2577-81.
  4. Fikree А., Aziz Q., Grahame R. Joint Hypermobility Syndrome. Rheum. Dis. Clin. North Am. 2013; 39 (2): 419-30.
  5. Наследственные нарушения соединительной ткани: Российские рекомендации. М., 2012. 76 с.
  6. Коншу Н.В. Стратификация риска возникновения остеоартроза у пациентов с семейной гипермобильностью суставов. Врач-аспирант. 2015; 2.2 (69): 234-2.
  7. Викторова И.А., Киселева Д.С., Коншу Н.В. Диагностика гипермобильности суставов в амбулаторной практике. Российские медицинские вести. 2011. № 3. С. 76-83.
  8. Schomacher J. Hyper- und Hypomobile Gelenke - Tendenzen kennen. Physiopraxis. 2012; 10 (11): 1250-51.
  9. Grahame R., Hakim A.J. Arachnodactyly - a key to diagnosing heritable disorders of connective tissue. Nat. Rev. Rheumatol. 2013; 9 (6): 358-64.
  10. Voermans N.C., Knoop H. Both pain and fatigue are important possible determinants of disability in patients with the Ehlers-Danlos syndrome hypermobility type. Disabil. Rehabil. 2011; 33 (8): 706-07.
  11. Loeys B.L., Dietz H.C., Braverman A.C. The Revised Ghent Nosology for the Marfan Syndrome. J. Med. Genetics. 2010; 4: 476-85.
  12. Morgaron Y. Tenascin-X increases the stiffness of collagen gels without affecting fibrillogenesis. Biophysical chemistry. 2011; 147:87-91.
  13. Grahame R. Joint hypermobility syndrome pain. Curr Pain Headache Rep. 2012; 13: 427-33.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Bionika Media, 2018

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies